These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8841316)

  • 1. Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation.
    Brey RL; Coull BM
    Stroke; 1996 Oct; 27(10):1719-20. PubMed ID: 8841316
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
    Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG
    Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral venous thrombosis and activated protein C resistance.
    Sánchez del Rio M; Gómez-Tortosa E; Outeriño J
    J Neurol; 1996 Oct; 243(10):727-8. PubMed ID: 8923308
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
    Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
    Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis.
    Weih M; Vetter B; Ziemer S; Mehraein S; Valdueza JM; Koscielny J; Kulozik AE; Einhäupl KM
    J Neurol; 1998 Mar; 245(3):149-52. PubMed ID: 9553844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives.
    Bridey F; Wolff M; Laissy JP; Morin V; Lefebvre M; de Prost D
    Thromb Haemost; 1995 Nov; 74(5):1382. PubMed ID: 8607129
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor V Leiden mutation in cerebral venous thrombosis.
    Zuber M; Toulon P; Marnet L; Mas JL
    Stroke; 1996 Oct; 27(10):1721-3. PubMed ID: 8841317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden).
    Pohl M; Zimmerhackl LB; Heinen F; Sutor AH; Schneppenheim R; Brandis M
    J Pediatr; 1998 Jan; 132(1):159-61. PubMed ID: 9470020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coincidence of factor V Leiden mutation and a mutation in the prothrombin gene at position 20210 in a patient with puerperal cerebral venous thrombosis.
    Weih M; Mehraein S; Valdueza JM; Einhäupl KM; Vetter B; Kulozik AE
    Stroke; 1998 Aug; 29(8):1739-40. PubMed ID: 9707222
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated protein C resistance and factor V Leiden mutation are risk factors for cerebral sinus thrombosis.
    Siegert CE; Smelt AH; de Bruin TW
    Stroke; 1997 Jun; 28(6):1291-2. PubMed ID: 9183366
    [No Abstract]   [Full Text] [Related]  

  • 11. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Presence of G1691A mutation on the gene of factor V in arterial thrombosis].
    Lellouche F; Dorval I; Dewilde J; Van Walleghem E
    Presse Med; 1995 May; 24(18):869. PubMed ID: 7638121
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral venous thrombosis and activated protein C resistance.
    Dulli DA; Luzzio CC; Williams EC; Schutta HS
    Stroke; 1996 Oct; 27(10):1731-3. PubMed ID: 8841319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central retinal vein thrombosis associated with resistance to activated protein C.
    Dhôte R; Bachmeyer C; Horellou MH; Toulon P; Christoforov B
    Am J Ophthalmol; 1995 Sep; 120(3):388-9. PubMed ID: 7661212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.
    Press RD; Goodnight SH
    West J Med; 1995 May; 162(5):450-2. PubMed ID: 7785262
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and clinical characteristics of inherited activated protein C resistance.
    Samama MM; Simon D; Horellou MH; Trossaërt M; Elalamy I; Conard J
    Haemostasis; 1996 Oct; 26 Suppl 4():315-30. PubMed ID: 8979137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated protein C resistance caused by factor V gene mutation: common coagulation defect in chronic venous leg ulcers?
    Peus D; Heit JA; Pittelkow MR
    J Am Acad Dermatol; 1997 Apr; 36(4):616-20. PubMed ID: 9092749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.
    Dahlbäck B
    J Lab Clin Med; 1995 May; 125(5):566-71. PubMed ID: 7738422
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease.
    Lesprit P; Wechsler B; Piette JC; Du-Boutin LT; Godeau P; Alhenc-Gelas M; Aiach M
    Ann Rheum Dis; 1995 Oct; 54(10):860. PubMed ID: 7492231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.